[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371094-105":3,"doc-detail-371094-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","circulating-potential-biomarkers-in-polycystic-ovary-syndrome-and-gynecologic-cancers-diagnostic-insights-from-a-systematic-review-and-meta-analysis","Circulating potential biomarkers in polycystic ovary syndrome and gynecologic cancers - Diagnostic insights from a systematic review and meta-analysis","","Systematic review and meta-analysis assess circulating liquid-biopsy biomarkers for diagnostic value and mechanistic roles in polycystic ovary syndrome (PCOS) and gynecologic cancers, especially endometrial (EC) and ovarian cancer (OC). Searches across PubMed and Embase included microRNAs, long non-coding RNAs, circular RNAs, and other non-coding RNAs; 46 PCOS, 27 EC, and 91 OC studies met criteria, and diagnostic performance metrics were synthesized via pooled meta-analysis where feasible.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/circulating-potential-biomarkers-in-polycystic-ovary-syndrome-and-gynecologic-cancers-diagnostic-insights-from-a-systematic-review-and-meta-analysis/371094/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/circulating-potential-biomarkers-in-polycystic-ovary-syndrome-and-gynecologic-cancers-diagnostic-insights-from-a-systematic-review-and-meta-analysis/371094.png","ImageObject",300,407,{"name":42,"@type":43},"hdkawk","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",16,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Which circulating biomarker types were evaluated for diagnostic potential?","Question",{"text":63,"@type":64},"The review included liquid-biopsy markers such as microRNAs, long non-coding RNAs, circular RNAs, and other non-coding RNAs.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How many eligible studies were included for each condition?",{"text":68,"@type":64},"The eligibility counts were 46 studies for PCOS, 27 for endometrial cancer, and 91 for ovarian cancer.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the pooled meta-analysis show for ovarian cancer?",{"text":72,"@type":64},"Pooled results reported promising AUC values for markers including miR-21, miR-200a, miR-200b, and miR-200c, supporting strong diagnostic potential.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371094,1790462364,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c",8,"Kumar et al. Journal of Ovarian Research (2026) 19:7 Journal of Ovarian Research  \n[https://doi.org/10.1186/s13048-025-01836-7](https://doi.org/10.1186/s13048-025-01836-7)  \nREVIEW Open Access  \nCirculating potential biomarkers in polycystic ovary syndrome and gynecologic cancers: Diagnostic insights from a systematic review and meta-analysis  \nSandeep Kumar 1*, Sandeep Sisodiya 1,2, Jyoti Rani 1, Priyanka Shah3, Chander Prakash Yadav 1, Komal Shah3, Bindiya Gupta4, Showket Hussain 1* and Shalini Singh 1  \nAbstract  \nBackground Epidemiological evidence indicates a higher risk of endometrial cancer (EC) and ovarian cancer (OC) in females suffering from Polycystic Ovary Syndrome (PCOS), highlighting that these disease groups might be sharing common molecular pathogenesis mechanisms. This systematic review and meta-analysis evaluated the unique and common liquid biopsy-based markers for their diagnostic potential as well as their role in the pathogenesis of PCOS, EC, and OC.  \nMethods A systematic search was conducted across PubMed and Embase databases to identify studies investigating circulating markers, including microRNAs, long non-coding RNAs, circular RNAs, and other non-coding RNAs for their diagnostic potential in PCOS, EC, and OC. A total of 46 studies for PCOS, 27 studies for EC, and 91 studies for OC met the eligibility criteria. Data on diagnostic performance, including area under the curve (AUC with 95% CI), sample size, sensitivity, and specificity, were synthesized from eligible studies, and meta-analysis was performed where feasible. Results A wide array of markers was listed along with their diagnostic potential across these disorders. miR-222-3p, miR-4488, and miR-151-5p performed well in PCOS, miR-27a, miR-145, miR-150-5p in EC, and miR-21, miR-1246, miR- 193a-5p, miR-200a, circBNC2 and circFOXP1 in OC. Pooled meta-analysis showed promising AUC values for miR-21 (0 . 81), miR-200a (0 . 86), miR-200b (0 . 84), and miR-200c (0 . 79) in OC, underscoring their strong diagnostic potential. For PCOS and EC, only two studies each were available for miR-223-3p and miR-27a, respectively. In subgroup analysis, miR-21 (0 . 81), miR-200c (0 . 78), miR-145 (0 . 89), and miR-27a (0 . 75) showed the highest diagnostic performance, but with high heterogeneity and a non-significant subgroup effect.  \nConclusion Circulating RNAs offer significant diagnostic, prognostic, and risk-stratification potential for PCOS and gynecologic cancers; however, standardized methodologies and large, independent, diverse cohort studies are needed to validate these findings and optimize clinical translation.  \n*Correspondence: Sandeep Kumar [sandeep.k@icmr.gov.in](sandeep.k@icmr.gov.in)[ ](sandeep.k@icmr.gov.in)Showket Hussain  \nshowket.hussain@gov.in  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nKumar et al. Journal of Ovarian Research (2026) 19:7 Page 2 o","cbCaitmBoqcHUtGQ","https://ap.wps.com/l/cbCaitmBoqcHUtGQ","pdf",2770803,23,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"Which circulating biomarker types were evaluated for diagnostic potential?\",\"answer\":\"The review included liquid-biopsy markers such as microRNAs, long non-coding RNAs, circular RNAs, and other non-coding RNAs.\"},{\"question\":\"How many eligible studies were included for each condition?\",\"answer\":\"The eligibility counts were 46 studies for PCOS, 27 for endometrial cancer, and 91 for ovarian cancer.\"},{\"question\":\"What did the pooled meta-analysis show for ovarian cancer?\",\"answer\":\"Pooled results reported promising AUC values for markers including miR-21, miR-200a, miR-200b, and miR-200c, supporting strong diagnostic potential.\"}]","Circulating potential biomarkers in polycystic ovary syndrome and gynecologic cancers - Diagnostic insights from a systematic review and meta-analysis | PDF",1790191229,58,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/862594ef6af6a7dd28e413697646bbba.webp",983,1310,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/71f16c6f8bc7e1812b80fea0242ae05c.webp",982,1309,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f31a5c745130c2628f9c9dfffd1320d5.webp",981,1308,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e44b347ff1fba9314c3fe8b848dff97.webp",980,1306,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,145,148,153,156,160],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":141,"doc_module":4,"doc_module_name":25,"category_name":142,"show_sort_weight":143,"slug":144},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":146,"slug":147},30,"research-report",{"id":149,"doc_module":4,"doc_module_name":25,"category_name":150,"show_sort_weight":151,"slug":152},9,"Religion & Spirituality",20,"religion-spirituality",{"id":151,"doc_module":4,"doc_module_name":25,"category_name":154,"show_sort_weight":151,"slug":155},"World Cup","world-cup",{"id":157,"doc_module":4,"doc_module_name":25,"category_name":158,"show_sort_weight":157,"slug":159},10,"Lifestyle","lifestyle",{"id":161,"doc_module":4,"doc_module_name":25,"category_name":162,"show_sort_weight":131,"slug":163},19,"General","general"]